Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
The efficacy of topical cyclosporin 2% in severe allergic conjunctivitis
Poster Details
First Author: I.Kilic TURKEY
Co Author(s):
Abstract Details
Purpose:
To report the efficacy of topical 2% topical cylosporine (CsA) in children with severe vernal conjunctivitis
Setting:
Aksehir State Hospital, Ankara, Turkey
Begum Bulam, MD, Baskent University, Ankara, Turkey
Methods:
Twenty patients with severe vernal conjunctivitis who were not responding to topical antihistamines, mast cell stabilizers and steroids were given topical CsA 2%. Ocular symptoms and findings were evaluated before and after treatment.
Results:
Twenty patients (12 boys, 8 girls) with a mean age of 9.2 (range 5-13 years) were included in the study. Significant relief in symptoms and significant improvement were observed with topical CsA 2% therapy (p<0.05, Wilcoxon signed rank test), and also the need for steroids was reduced. No side effects were observed during the follow-up period.
Conclusions:
Topical CsA is an effective and safe treatment option in patients with severe vernal conjunctivitis FINANCIAL INTEREST: NONE
